The DOI matches its Crossref record; 18 of the 20 references it cites were found in a registry or an index.
The CERAD Neuropsychologic Battery Total Score and the Progression of Alzheimer Disease
Open accessAbstract
OBJECTIVE: To establish the Consortium to Establish a Registry for Alzheimer's Disease (CERAD) neuropsychologic battery as a valid measure of cognitive progression in Alzheimer disease (AD) by deriving annualized CERAD Total Change Scores and corresponding confidence intervals in AD and controls from which to define clinically meaningful change. METHOD: Subjects included 383 normal control (NC) and 655 AD subjects with serial data from the CERAD registry database. Annualized CERAD Total Change Scores were derived and Reliable Change Indexes (RCIs) calculated to establish statistically reliable change values. CERAD Change Scores were compared with annualized change scores from the Mini-Mental State Examination (MMSE), Clinical Dementia Rating Scale (CDR) Sum of Boxes, and Blessed Dementia Rating Scale (BDRS). RESULTS: For the CERAD Total Score, the AD sample showed significantly greater decline than the NC sample over the 4-year interval, with AD subjects declining an average of 22.2 points compared with the NCs' improving an average 2.8 points from baseline to last visit [Group x Time interaction [F(4,1031)=246.08, P<0.001)]. By Visit 3, the majority of AD subjects (65.2%) showed a degree of cognitive decline that fell outside the RCI. CERAD Change Scores significantly correlated (P<0.001) with MMSE (r=-0.66), CDR (r=-0.42), and BDRS (r=-0.38) change scores. CONCLUSION: Results support the utility of the CERAD Total Score as a measure of AD progression and provide comparative data for annualized change in CERAD Total Score and other summary measures.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Experts have defined clinically meaningful cognitive decline as a decline in cognitive function of 0.5 or more SDs from baseline cognitive scores.36,37,38”
From Sex differences in cognitive decline among US adults (2021) · cites this paper as [37]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Jacobson, N. S., & Truax, P. (1991) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.59.1.12 · Cited by 7,770
Moms, J. C., Heyman, A., Mohs, R. C., Hughes, J. P., van Belle, G., Fillenbaum, G., Mellits, E. D., & Clark, C. (1989) · Neurology · doi:10.1212/wnl.39.9.1159 · Cited by 4,130
Blessed, G., Tomlinson, B. E., & Roth, M. (1968) · British Journal of Psychiatry · doi:10.1192/bjp.114.512.797 · Cited by 4,117
Welsh, K. A., Butters, N., Mohs, R. C., Beekly, D., Edland, S., Fillenbaum, G., & Heyman, A. (1994) · Neurology · doi:10.1212/wnl.44.4.609 · Cited by 951
Clinical Dementia Rating (CDR)
Gauthier, S. G. (2001) · CRC Press eBooks · doi:10.3109/9780203213896-34 · Cited by 696
Individual change after epilepsy surgery: Practice effects and base-rate information.
Chelune, G. J., Naugle, R. I., Lüders, H. O., Sedlak, J., & Awad, I. A. (1993) · Neuropsychology · doi:10.1037/0894-4105.7.1.41 · Cited by 599
Detection and Staging of Dementia in Alzheimer's Disease
Welsh-Bohmer, K. A. (1992) · Archives of Neurology · doi:10.1001/archneur.1992.00530290030008 · Cited by 473
Morris, J. C., Edland, S., Clark, C., Galasko, D., Koss, E., Mohs, R., van Belle, G., Fillenbaum, G., & Heyman, A. (1993) · Neurology · doi:10.1212/wnl.43.12.2457 · Cited by 441
Cited by
Sorted by citations
Items 101–110 of 110
Lower Urinary Tract Symptoms and Cognitive Impairment Among Participants in the REGARDS Cohort Study
Markland, A. D., Kennedy, R., Crowe, M. G., Williams, B., Munoz, C., Elgayar, S., Burgio, K. L., & Howard, V. J. (2026) · Journal of the American Geriatrics Society · doi:10.1111/jgs.70382
Blood mitochondrial heteroplasmic variants and cognitive performance in late midlife: REGARDS study
Prada, D., Morava‐Kozicz, E., Rajendrakumar, A. L., Kupsco, A. J., Lesseur, C., Irizar, H., Cantú-de-León, D., García-Cuellar, C., Ramírez, A., González-Ruíz, J., et al. (2026) · BMC Neurology · doi:10.1186/s12883-026-04857-x
Demina, A., Casey, D., Amaral, S., Fabus, M. S., Béjot, Y., & Trojak, B. (2026) · BMJ Open · doi:10.1136/bmjopen-2026-117329
Multi-Trajectory Pseudotime Inference via Permutation FactorizationsPreprint
Farina, R., Wang, Y., Gabitto, M. I., Agrawal, A., & Mena, G. E. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.27.728207
Shahu, A., Xia, W., Wei, Y., & Malinsky, D. (2026) · Statistics in Medicine · doi:10.1002/sim.70604
Wiechmann, D., Günes, A. R., Kerz, E., Qiao, Y., Köhne, M., & Sprick, U. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877261456294 · Cited by 2
Krohn, F., Sarkar, M., Schütze, H., Iliopoulos, P., Penalba‐Sánchez, L., Hämmerer, D., Yakupov, R., Lüsebrink, F., Spottke, A. E., Schneider, A., et al. (2026) · Brain Communications · doi:10.1093/braincomms/fcag238
Virlley, M., Xi, Y., Bell, N. M., Pruitt, T., Guo, L., White, S., Yu, F. F., Lacritz, L. H., Rossetti, H. C., Cullum, C. M., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.29.735283
Self-citationde Havenon, A., Sheth, K. N., Fredericks, C. A., & Brickman, A. M. (2026) · Neurotherapeutics · doi:10.1016/j.neurot.2026.e01068
A cell-type-directed drug repurposing framework for Alzheimer's disease subtypes
Li, Y., Tang, X., Serras, C. P., Tang, A., Oskotsky, T., & Sirota, M. (2026) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2026.10.019
Metadata
- Authors
- Rossetti, H. C., Munro Cullum, C., Hynan, L. S., & Lacritz, L. H.
- Affiliations
- The University of Texas Southwestern Medical Center (US)
- Corresponding author
- Rossetti, Heidi C.
- Hynan, Linda S.
- Lacritz, Laura H.
- Venue
- Alzheimer Disease & Associated Disorders
- Published
- 2010-04
- Volume
- 24
- Issue
- 2
- Pages
- 138-142
- ISSN
- 0893-0341 (ISSN-L)
- PMC
- PMC2920638
- OpenAlex
- W1981940800
- Cited by
- 110
- References
- 20
- Citations by year
- 2026: 12 · 2025: 12 · 2024: 8 · 2023: 7 · 2022: 12 · 2021: 12 · 2020: 8 · 2019: 6 · 2018: 5 · 2017: 2 · 2016: 2 · 2015: 4 · 2014: 5 · 2013: 5 · 2012: 5
- FWCI
- 3.28
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Alzheimer Disease & Associated Disorders (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute on Aging (P30AG012300, P30AG-12300)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Social Sciences › Psychology › Applied Psychology › Psychological Testing and Assessment
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- Alzheimer's disease, cognitive decline, disease progression, reliable change index, Mini-Mental State Examination, Clinical Dementia Rating, healthy controls, clinical outcome measures
- MeSH terms
- Aged, Alzheimer Disease, Female, Humans, Male, Neuropsychological Tests, Disease Progression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
